Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Claudio D. Schteingart
Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
Related publications
Role of Glucagon-Like Peptide–2 Deficiency in Neonatal Short-Bowel Syndrome Using Neonatal Piglets
Pediatric Research
Child Health
Pediatrics
Perinatology
Orphan Designation: Human Glucagon-Like Peptide-2 Analogue Linked to a Human Immunoglobulin Fc Fragment, Treatment of Short Bowel Syndrome
Case Medical Research
Novel Mono-Lipidated Dimeric Glucagon-Like Peptide-1 Receptor Agonist With Improved Long-Acting and Hypoglycemic Activity
RSC Advances
Chemistry
Chemical Engineering
Patient Preferences for Frequency of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Injections in the Treatment of Type 2 Diabetes
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Biological Function for Glucagon-Like Peptide-2
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Elevated Plasma Glucagon-Like Peptide 1 and 2 Concentrations in Ileum-Resected Short Bowel Patients With a Preserved Colon
Gastroenterology
Hepatology
Gastroenterology
Remission of Bile Acid Malabsorption Symptoms Following Treatment With the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide
Gastroenterology
Hepatology
Gastroenterology
The Key Role of a Glucagon-Like Peptide-1 Receptor Agonist in Body Fat Redistribution
Journal of Endocrinology
Endocrinology
Metabolism
Diabetes
A Nonpeptidic Agonist of Glucagon-Like Peptide 1 Receptors With Efficacy in Diabeticdb/Dbmice
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
